Law360, New York (June 12, 2006, 12:00 AM ET) -- Bringing a long-running legal battle to an end, Barr Laboratories Inc. has agreed to a $22.5 million settlement deal with Invamed Inc. and Apothecon Inc. over the raw material source for the blood thinner Warfarin Sodium.
Under the terms of the deal, Barr will fork over a one-time payment of $22.5 million to Invamed and Apothecon, both of which are owned by Sandoz Inc., a unit of Novartis. The payment, totaling approximately 13 cents per share, will be reported in Barr’s results for the quarter ending...
Barr Settles With Sandoz For $22.5M Over Blood Thinner
To view the full article, take a free trial now.
